Natural Products
| Catalog No. | Information |
| CFN95532 | Caffeoylcalleryanin Caffeoylcalleryanin exerted strong 15-LOX inhibitory activity; IC50 values was 1.59 μM.A. pulchra leaves ethanol extract (EEAPL) affords compounds with antiviral activity, mainly against DENV-2. respectively, while Caffeoylcalleryanin was the most effective anti-DENV-2 constituent, with a SI of 20.0. |
| CFN95531 | (3,4-Dihydroxyphenyl)methyl 3-(beta-D-glucopyranosyloxy)-4-hydroxybenzoate |
| CFN95530 | Odontoside |
| CFN95529 | Herbacetin 3-sophoroside-8-glucoside |
| CFN95528 | Gossypetin 3-sophoroside-8-glucoside |
| CFN95527 | New compound 18 |
| CFN95526 | Hainanic acid B |
| CFN95525 | Regaloside I Regaloside I, which has the structure of phenylpropanolglycerol glycoside, acts as an active compound that inhibits the upregulation of CAPZA1 and inhibits UVA-induced changes in HDF shape, which in turn inhibits collagen reduction. |
| CFN95524 | Catechin 7-O-beta-D-glucopyranoside Catechin 7-O-beta-D-glucopyranoside has intestinal anti-inflammatory activity. Catechin 7-O-beta-D-glucopyranoside has a protective effect against STZ-induced cell damage by its antioxidant effects and the attenuation of mitochondrial dysfunction. Catechin 7-O-β-D-glucopyranoside has strong inhibitory activity against α-amylase and α-glucosidase. Catechin 7-O-β-D-glucopyranoside has the activity of inhibiting protein glycation. |
| CFN95523 | Dihydroconfertin |
| CFN95522 | 5-Hydroxy-4a,8-dimethyl-3-methylen-decahydroazuleno[6,5-b]furan-2(3H)-on |
| CFN95521 | Hosenkoside D |
| CFN95520 | Hosenkoside L |
| CFN95519 | 10-Deacetylcephalomannine 10-Deacetylcephalomannin is also active against PS leukemia in vivo, but it is particularly unstable and forms an equilibrium mixture with its cytotoxic C-7 epimer. 10-Deacetylcephalomannine has growth inhibitory activity against human cancer cell lines such as cervical HeLa adenocarcinoma. |
| CFN95518 | Ganoderic acid GS-3 |
| CFN95517 | Ganoderenic acid G |
| CFN95516 | Ganoderic acid J Ganoderic acid J is a natural terpenoid isolated from the Fungus Ganoderma lucidum. Ganoderic acid J possesses anti-inflammatory anti-inflammatory activity. |
| CFN95515 | 12beta-Acetoxy-7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanosta-8,20-dien-26-oic acid |
| CFN95514 | Ganoderic acid Df Ganoderic acid Df exhibited potent human aldose reductase inhibitory activity, with an IC(50) of 22.8 μM in vitro. Ganoderic acid Df as a potential anticancer agent. |
| CFN95513 | Ganolucidic acid B Ganolucidic acids B showd induction ability of hPXR-mediated CYP3A4 expression. |
| CFN95512 | Alopecurone A Alopecurone A exhibits potent inhibitory activity on MRP1.Alopecurone A exhibits cytotoxic activity in DU145 (prostate cancer cell line) and MCF-7 (breast cancer cell line) cell lines with IC50 values of 2.44 and 5.44 μg/mL. respectively.Alopecurone A has antibacterial activity against methicillin-resistant Staphylococcus aureus. |
| CFN95511 | 2-(2,4-Dihydroxyphenyl)-5,6-methylenedioxybenzofuran (ABF) |
| CFN95510 | Sophoraflavone A |
| CFN95509 | 8-epi-Confertin |
| CFN95508 | 4-O-Coumaroylquinic acid 4-O-Coumaroylquinic acid has potential inhibitory capacity on the spike glycoprotein trimer of SARS-CoV-2.4-O-Coumaroylquinic acid has inhibitory activity against LdNH.4-O-Coumaroylquinic acid has certain antioxidant capacity. |
| CFN95507 | 5-O-Coumaroylquinic acid 5-O-Coumaroylquinic acid (3-O-Coumaroylquinic acid), exhibits significant inhibition of PTP1B and a concentration-dependent inhibitory effect on α-glucosidase, thereby demonstrating anti-hyperglycemic properties. Additionally, this compound enhances glucose uptake and inhibits PTP1B in vitro, emphasizing its potential therapeutic applications in glucose regulation. 5-O-Coumaroylquinic acid is a potent, reversible, non-competitive α-amylase inhibitor with an IC50 value of 69.39 μM. |
| CFN95506 | Quercetin-3-O-[alpha-L-rhamnose-(1->2)-beta-D-glucopyranosyl]-5-O-beta-D-glucopyranoside |
| CFN95505 | 12beta-Acetoxy-3,7,11,15,23-pentaoxo-lanost-8,20-dien-26-oic acid |
| CFN95504 | Ganoweberianic acid E |
| CFN95503 | Kidjolanin |
| CFN95502 | Butesuperin B-7''-O-beta-glucopyranoside |
| CFN95501 | erythro-Austrobailignan-6 Erythro-austrobailignan-6 has anticancer activity. EA6-induced apoptosis is mediated by p38 MAPK and caspase-3 activation in both cells. EA6 significantly reduced HER2/EGFR/integrin β3 expression and Src phosphorylation, which was dependent on p38 MAPK activation in 4T-1 and MCF-7 cells.erythro-Austrobailignan-6 induces apoptosis in AGS and NCI-N87 gastric cancer cell lines.Erythro-austrobailignan-6 has antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals. Erythro-Austrobailignan-6 has antifungal activity. |
| CFN95500 | Massonianoside D |
| CFN95499 | beta-Hydroxyacteoside |
| CFN95498 | Campneoside II Campneoside II exhibits excellent anti-complement activity. |
| CFN95496 | 3-Oxo-alpha-ilexanolic acid |
| CFN95495 | Benzylpropyl acetate |
| CFN95494 | Isorhamnetin-3-O-rutinoside-7-O-glucoside |
| CFN95493 | 2',4'-Dihydroxychalcone 2',4'-Dihydroxychalcone, in combination with nalidixic acid (HY-B0398), exhibits synergistic effects against E. coli by reducing membrane permeability. 2',4'-Dihydroxychalcone (2',4'-DHC) as a compound with Hsp90 inhibitory and antifungal effects. |
| CFN95492 | (R)-Mucronulatol (R)-Mucronulatol shows antibacterial activity against Escherichia coli, Bacillus cereus, Staphylococcus aureus, Erwinia carotovora and Bacillus subtili, with MICs of 15.5, 15.5, 7.8, 7.8, 15.5 μg/mL respectively. |
| CFN95491 | Oxytroflavoside D |
| CFN95490 | Oxytroflavoside B |
| CFN95489 | Oxytroflavoside F |
| CFN95488 | Isorhamnetin 3,5-O-diglucoside |
| CFN95487 | Kaempferol 3,5-O-diglucoside |
| CFN95486 | Quercetin 3,5-O-diglucoside |
| CFN95485 | 6-Methoxyfraxinellone |
| CFN95484 | Giganteone C |
| CFN95483 | Maingayone B |
| CFN95482 | Kihadanin D |
